Selected research
Industry Research
Proteomics Research Services Industry Research Report 2026
Market perspective
The global Proteomics Research Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Proteomics Research Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Proteomics Research Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Proteomics Research Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Proteomics Research Services include PTM BIO, Standard Biotools, Labcorp, BostonGene, APTBIO, Cell Signaling Technology (CST), Inotiv, Bruker Spatial Biology and BGI Genomics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Proteomics Research Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Proteomics Research Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Proteomics Research Services Market by Company
PTM BIO
Standard Biotools
Labcorp
BostonGene
APTBIO
Cell Signaling Technology (CST)
Inotiv
Bruker Spatial Biology
BGI Genomics
Biognosys
Crown Bioscience
Eurofins Scientific
Charles River Laboratories
Discovery Life Sciences
Shanghai OE Biotech
Biodesix
Novogene
OmicScouts (Momentum Biotechnologies)
Lc-Bio Technologies
Creative Proteomics
Metware Biotechnology
GENEWIZ (Azenta Life Sciences)
CDI Labs
Evotec
MS Bioworks
Shanghai Bioprofile
MtoZ-Biolabs
Shanghai Majorbio Bio-Pharm
Firalis Molecular Precision
CD Genomics
MRM Proteomics
Panome Bio
Beijing Biomarker Technologies
Sampled (Infinity Biologix)
Sinotech Genomics
Applied Biomics
Westlake Omics
Sapient Bioanalytics
RxCelerate
Vizgen
Allumiqs
VProteomics
Precision Biomarker Laboratories (PBL)
Proteome Sciences
Proteomics International
TATAA Biocenter
Cosmos Wisdom
Olink (Thermo Fisher Scientific)
SomaLogic (Illumina)
CellCarta
Proteomics Research Services Segment by Type
Standard Proteomics
Modified Proteomics
Spatial Proteomics
Blood Proteomics
Other Proteomics
Proteomics Research Services Segment by Application
Clinical Diagnostics
Drug Discovery
Others
Proteomics Research Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Proteomics Research Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Proteomics Research Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Proteomics Research Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Proteomics Research Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Standard Proteomics
- Modified Proteomics
- Spatial Proteomics
- Blood Proteomics
- Other Proteomics
Applications
- Clinical Diagnostics
- Drug Discovery
- Others
Companies covered
- PTM BIO
- Standard Biotools
- Labcorp
- BostonGene
- APTBIO
- Cell Signaling Technology (CST)
- Inotiv
- Bruker Spatial Biology
- BGI Genomics
- Biognosys
- Crown Bioscience
- Eurofins Scientific
- Charles River Laboratories
- Discovery Life Sciences
- Shanghai OE Biotech
- Biodesix
- Novogene
- OmicScouts (Momentum Biotechnologies)
- Lc-Bio Technologies
- Creative Proteomics
- Metware Biotechnology
- GENEWIZ (Azenta Life Sciences)
- CDI Labs
- Evotec
- MS Bioworks
- Shanghai Bioprofile
- MtoZ-Biolabs
- Shanghai Majorbio Bio-Pharm
- Firalis Molecular Precision
- CD Genomics
- MRM Proteomics
- Panome Bio
- Beijing Biomarker Technologies
- Sampled (Infinity Biologix)
- Sinotech Genomics
- Applied Biomics
- Westlake Omics
- Sapient Bioanalytics
- RxCelerate
- Vizgen
- Allumiqs
- VProteomics
- Precision Biomarker Laboratories (PBL)
- Proteome Sciences
- Proteomics International
- TATAA Biocenter
- Cosmos Wisdom
- Olink (Thermo Fisher Scientific)
- SomaLogic (Illumina)
- CellCarta
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Proteomics Research Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Standard Proteomics
- 2.2.3 Modified Proteomics
- 2.2.4 Spatial Proteomics
- 2.2.5 Blood Proteomics
- 2.2.6 Other Proteomics
- 2.3 Proteomics Research Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Diagnostics
- 2.3.3 Drug Discovery
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Proteomics Research Services Breakdown Data by Type
- 3.1 Global Proteomics Research Services Historic Market Size by Type (2021-2026)
- 3.2 Global Proteomics Research Services Forecasted Market Size by Type (2027-2032)
4 Proteomics Research Services Breakdown Data by Application
- 4.1 Global Proteomics Research Services Historic Market Size by Application (2021-2026)
- 4.2 Global Proteomics Research Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Proteomics Research Services Market Perspective (2021-2032)
- 5.2 Global Proteomics Research Services Growth Trends by Region
- 5.2.1 Global Proteomics Research Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Proteomics Research Services Historic Market Size by Region (2021-2026)
- 5.2.3 Proteomics Research Services Forecasted Market Size by Region (2027-2032)
- 5.3 Proteomics Research Services Market Dynamics
- 5.3.1 Proteomics Research Services Industry Trends
- 5.3.2 Proteomics Research Services Market Drivers
- 5.3.3 Proteomics Research Services Market Challenges
- 5.3.4 Proteomics Research Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Proteomics Research Services Players by Revenue
- 6.1.1 Global Top Proteomics Research Services Players by Revenue (2021-2026)
- 6.1.2 Global Proteomics Research Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Proteomics Research Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Proteomics Research Services Head Office and Area Served
- 6.4 Global Proteomics Research Services Players, Product Type & Application
- 6.5 Global Proteomics Research Services Manufacturers Established Date
- 6.6 Global Proteomics Research Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Proteomics Research Services Market Size (2021-2032)
- 7.2 North America Proteomics Research Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Proteomics Research Services Market Size by Country (2021-2026)
- 7.4 North America Proteomics Research Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Proteomics Research Services Market Size (2021-2032)
- 8.2 Europe Proteomics Research Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Proteomics Research Services Market Size by Country (2021-2026)
- 8.4 Europe Proteomics Research Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Proteomics Research Services Market Size (2021-2032)
- 9.2 Asia-Pacific Proteomics Research Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Proteomics Research Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Proteomics Research Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Proteomics Research Services Market Size (2021-2032)
- 10.2 South America Proteomics Research Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Proteomics Research Services Market Size by Country (2021-2026)
- 10.4 South America Proteomics Research Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Proteomics Research Services Market Size (2021-2032)
- 11.2 Middle East & Africa Proteomics Research Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Proteomics Research Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Proteomics Research Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 PTM BIO
- 12.1.1 PTM BIO Company Information
- 12.1.2 PTM BIO Business Overview
- 12.1.3 PTM BIO Revenue in Proteomics Research Services Business (2021-2026)
- 12.1.4 PTM BIO Proteomics Research Services Product Portfolio
- 12.1.5 PTM BIO Recent Developments
- 12.2 Standard Biotools
- 12.2.1 Standard Biotools Company Information
- 12.2.2 Standard Biotools Business Overview
- 12.2.3 Standard Biotools Revenue in Proteomics Research Services Business (2021-2026)
- 12.2.4 Standard Biotools Proteomics Research Services Product Portfolio
- 12.2.5 Standard Biotools Recent Developments
- 12.3 Labcorp
- 12.3.1 Labcorp Company Information
- 12.3.2 Labcorp Business Overview
- 12.3.3 Labcorp Revenue in Proteomics Research Services Business (2021-2026)
- 12.3.4 Labcorp Proteomics Research Services Product Portfolio
- 12.3.5 Labcorp Recent Developments
- 12.4 BostonGene
- 12.4.1 BostonGene Company Information
- 12.4.2 BostonGene Business Overview
- 12.4.3 BostonGene Revenue in Proteomics Research Services Business (2021-2026)
- 12.4.4 BostonGene Proteomics Research Services Product Portfolio
- 12.4.5 BostonGene Recent Developments
- 12.5 APTBIO
- 12.5.1 APTBIO Company Information
- 12.5.2 APTBIO Business Overview
- 12.5.3 APTBIO Revenue in Proteomics Research Services Business (2021-2026)
- 12.5.4 APTBIO Proteomics Research Services Product Portfolio
- 12.5.5 APTBIO Recent Developments
- 12.6 Cell Signaling Technology (CST)
- 12.6.1 Cell Signaling Technology (CST) Company Information
- 12.6.2 Cell Signaling Technology (CST) Business Overview
- 12.6.3 Cell Signaling Technology (CST) Revenue in Proteomics Research Services Business (2021-2026)
- 12.6.4 Cell Signaling Technology (CST) Proteomics Research Services Product Portfolio
- 12.6.5 Cell Signaling Technology (CST) Recent Developments
- 12.7 Inotiv
- 12.7.1 Inotiv Company Information
- 12.7.2 Inotiv Business Overview
- 12.7.3 Inotiv Revenue in Proteomics Research Services Business (2021-2026)
- 12.7.4 Inotiv Proteomics Research Services Product Portfolio
- 12.7.5 Inotiv Recent Developments
- 12.8 Bruker Spatial Biology
- 12.8.1 Bruker Spatial Biology Company Information
- 12.8.2 Bruker Spatial Biology Business Overview
- 12.8.3 Bruker Spatial Biology Revenue in Proteomics Research Services Business (2021-2026)
- 12.8.4 Bruker Spatial Biology Proteomics Research Services Product Portfolio
- 12.8.5 Bruker Spatial Biology Recent Developments
- 12.9 BGI Genomics
- 12.9.1 BGI Genomics Company Information
- 12.9.2 BGI Genomics Business Overview
- 12.9.3 BGI Genomics Revenue in Proteomics Research Services Business (2021-2026)
- 12.9.4 BGI Genomics Proteomics Research Services Product Portfolio
- 12.9.5 BGI Genomics Recent Developments
- 12.10 Biognosys
- 12.10.1 Biognosys Company Information
- 12.10.2 Biognosys Business Overview
- 12.10.3 Biognosys Revenue in Proteomics Research Services Business (2021-2026)
- 12.10.4 Biognosys Proteomics Research Services Product Portfolio
- 12.10.5 Biognosys Recent Developments
- 12.11 Crown Bioscience
- 12.11.1 Crown Bioscience Company Information
- 12.11.2 Crown Bioscience Business Overview
- 12.11.3 Crown Bioscience Revenue in Proteomics Research Services Business (2021-2026)
- 12.11.4 Crown Bioscience Proteomics Research Services Product Portfolio
- 12.11.5 Crown Bioscience Recent Developments
- 12.12 Eurofins Scientific
- 12.12.1 Eurofins Scientific Company Information
- 12.12.2 Eurofins Scientific Business Overview
- 12.12.3 Eurofins Scientific Revenue in Proteomics Research Services Business (2021-2026)
- 12.12.4 Eurofins Scientific Proteomics Research Services Product Portfolio
- 12.12.5 Eurofins Scientific Recent Developments
- 12.13 Charles River Laboratories
- 12.13.1 Charles River Laboratories Company Information
- 12.13.2 Charles River Laboratories Business Overview
- 12.13.3 Charles River Laboratories Revenue in Proteomics Research Services Business (2021-2026)
- 12.13.4 Charles River Laboratories Proteomics Research Services Product Portfolio
- 12.13.5 Charles River Laboratories Recent Developments
- 12.14 Discovery Life Sciences
- 12.14.1 Discovery Life Sciences Company Information
- 12.14.2 Discovery Life Sciences Business Overview
- 12.14.3 Discovery Life Sciences Revenue in Proteomics Research Services Business (2021-2026)
- 12.14.4 Discovery Life Sciences Proteomics Research Services Product Portfolio
- 12.14.5 Discovery Life Sciences Recent Developments
- 12.15 Shanghai OE Biotech
- 12.15.1 Shanghai OE Biotech Company Information
- 12.15.2 Shanghai OE Biotech Business Overview
- 12.15.3 Shanghai OE Biotech Revenue in Proteomics Research Services Business (2021-2026)
- 12.15.4 Shanghai OE Biotech Proteomics Research Services Product Portfolio
- 12.15.5 Shanghai OE Biotech Recent Developments
- 12.16 Biodesix
- 12.16.1 Biodesix Company Information
- 12.16.2 Biodesix Business Overview
- 12.16.3 Biodesix Revenue in Proteomics Research Services Business (2021-2026)
- 12.16.4 Biodesix Proteomics Research Services Product Portfolio
- 12.16.5 Biodesix Recent Developments
- 12.17 Novogene
- 12.17.1 Novogene Company Information
- 12.17.2 Novogene Business Overview
- 12.17.3 Novogene Revenue in Proteomics Research Services Business (2021-2026)
- 12.17.4 Novogene Proteomics Research Services Product Portfolio
- 12.17.5 Novogene Recent Developments
- 12.18 OmicScouts (Momentum Biotechnologies)
- 12.18.1 OmicScouts (Momentum Biotechnologies) Company Information
- 12.18.2 OmicScouts (Momentum Biotechnologies) Business Overview
- 12.18.3 OmicScouts (Momentum Biotechnologies) Revenue in Proteomics Research Services Business (2021-2026)
- 12.18.4 OmicScouts (Momentum Biotechnologies) Proteomics Research Services Product Portfolio
- 12.18.5 OmicScouts (Momentum Biotechnologies) Recent Developments
- 12.19 Lc-Bio Technologies
- 12.19.1 Lc-Bio Technologies Company Information
- 12.19.2 Lc-Bio Technologies Business Overview
- 12.19.3 Lc-Bio Technologies Revenue in Proteomics Research Services Business (2021-2026)
- 12.19.4 Lc-Bio Technologies Proteomics Research Services Product Portfolio
- 12.19.5 Lc-Bio Technologies Recent Developments
- 12.20 Creative Proteomics
- 12.20.1 Creative Proteomics Company Information
- 12.20.2 Creative Proteomics Business Overview
- 12.20.3 Creative Proteomics Revenue in Proteomics Research Services Business (2021-2026)
- 12.20.4 Creative Proteomics Proteomics Research Services Product Portfolio
- 12.20.5 Creative Proteomics Recent Developments
- 12.21 Metware Biotechnology
- 12.21.1 Metware Biotechnology Company Information
- 12.21.2 Metware Biotechnology Business Overview
- 12.21.3 Metware Biotechnology Revenue in Proteomics Research Services Business (2021-2026)
- 12.21.4 Metware Biotechnology Proteomics Research Services Product Portfolio
- 12.21.5 Metware Biotechnology Recent Developments
- 12.22 GENEWIZ (Azenta Life Sciences)
- 12.22.1 GENEWIZ (Azenta Life Sciences) Company Information
- 12.22.2 GENEWIZ (Azenta Life Sciences) Business Overview
- 12.22.3 GENEWIZ (Azenta Life Sciences) Revenue in Proteomics Research Services Business (2021-2026)
- 12.22.4 GENEWIZ (Azenta Life Sciences) Proteomics Research Services Product Portfolio
- 12.22.5 GENEWIZ (Azenta Life Sciences) Recent Developments
- 12.23 CDI Labs
- 12.23.1 CDI Labs Company Information
- 12.23.2 CDI Labs Business Overview
- 12.23.3 CDI Labs Revenue in Proteomics Research Services Business (2021-2026)
- 12.23.4 CDI Labs Proteomics Research Services Product Portfolio
- 12.23.5 CDI Labs Recent Developments
- 12.24 Evotec
- 12.24.1 Evotec Company Information
- 12.24.2 Evotec Business Overview
- 12.24.3 Evotec Revenue in Proteomics Research Services Business (2021-2026)
- 12.24.4 Evotec Proteomics Research Services Product Portfolio
- 12.24.5 Evotec Recent Developments
- 12.25 MS Bioworks
- 12.25.1 MS Bioworks Company Information
- 12.25.2 MS Bioworks Business Overview
- 12.25.3 MS Bioworks Revenue in Proteomics Research Services Business (2021-2026)
- 12.25.4 MS Bioworks Proteomics Research Services Product Portfolio
- 12.25.5 MS Bioworks Recent Developments
- 12.26 Shanghai Bioprofile
- 12.26.1 Shanghai Bioprofile Company Information
- 12.26.2 Shanghai Bioprofile Business Overview
- 12.26.3 Shanghai Bioprofile Revenue in Proteomics Research Services Business (2021-2026)
- 12.26.4 Shanghai Bioprofile Proteomics Research Services Product Portfolio
- 12.26.5 Shanghai Bioprofile Recent Developments
- 12.27 MtoZ-Biolabs
- 12.27.1 MtoZ-Biolabs Company Information
- 12.27.2 MtoZ-Biolabs Business Overview
- 12.27.3 MtoZ-Biolabs Revenue in Proteomics Research Services Business (2021-2026)
- 12.27.4 MtoZ-Biolabs Proteomics Research Services Product Portfolio
- 12.27.5 MtoZ-Biolabs Recent Developments
- 12.28 Shanghai Majorbio Bio-Pharm
- 12.28.1 Shanghai Majorbio Bio-Pharm Company Information
- 12.28.2 Shanghai Majorbio Bio-Pharm Business Overview
- 12.28.3 Shanghai Majorbio Bio-Pharm Revenue in Proteomics Research Services Business (2021-2026)
- 12.28.4 Shanghai Majorbio Bio-Pharm Proteomics Research Services Product Portfolio
- 12.28.5 Shanghai Majorbio Bio-Pharm Recent Developments
- 12.29 Firalis Molecular Precision
- 12.29.1 Firalis Molecular Precision Company Information
- 12.29.2 Firalis Molecular Precision Business Overview
- 12.29.3 Firalis Molecular Precision Revenue in Proteomics Research Services Business (2021-2026)
- 12.29.4 Firalis Molecular Precision Proteomics Research Services Product Portfolio
- 12.29.5 Firalis Molecular Precision Recent Developments
- 12.30 CD Genomics
- 12.30.1 CD Genomics Company Information
- 12.30.2 CD Genomics Business Overview
- 12.30.3 CD Genomics Revenue in Proteomics Research Services Business (2021-2026)
- 12.30.4 CD Genomics Proteomics Research Services Product Portfolio
- 12.30.5 CD Genomics Recent Developments
- 12.31 MRM Proteomics
- 12.31.1 MRM Proteomics Company Information
- 12.31.2 MRM Proteomics Business Overview
- 12.31.3 MRM Proteomics Revenue in Proteomics Research Services Business (2021-2026)
- 12.31.4 MRM Proteomics Proteomics Research Services Product Portfolio
- 12.31.5 MRM Proteomics Recent Developments
- 12.32 Panome Bio
- 12.32.1 Panome Bio Company Information
- 12.32.2 Panome Bio Business Overview
- 12.32.3 Panome Bio Revenue in Proteomics Research Services Business (2021-2026)
- 12.32.4 Panome Bio Proteomics Research Services Product Portfolio
- 12.32.5 Panome Bio Recent Developments
- 12.33 Beijing Biomarker Technologies
- 12.33.1 Beijing Biomarker Technologies Company Information
- 12.33.2 Beijing Biomarker Technologies Business Overview
- 12.33.3 Beijing Biomarker Technologies Revenue in Proteomics Research Services Business (2021-2026)
- 12.33.4 Beijing Biomarker Technologies Proteomics Research Services Product Portfolio
- 12.33.5 Beijing Biomarker Technologies Recent Developments
- 12.34 Sampled (Infinity Biologix)
- 12.34.1 Sampled (Infinity Biologix) Company Information
- 12.34.2 Sampled (Infinity Biologix) Business Overview
- 12.34.3 Sampled (Infinity Biologix) Revenue in Proteomics Research Services Business (2021-2026)
- 12.34.4 Sampled (Infinity Biologix) Proteomics Research Services Product Portfolio
- 12.34.5 Sampled (Infinity Biologix) Recent Developments
- 12.35 Sinotech Genomics
- 12.35.1 Sinotech Genomics Company Information
- 12.35.2 Sinotech Genomics Business Overview
- 12.35.3 Sinotech Genomics Revenue in Proteomics Research Services Business (2021-2026)
- 12.35.4 Sinotech Genomics Proteomics Research Services Product Portfolio
- 12.35.5 Sinotech Genomics Recent Developments
- 12.36 Applied Biomics
- 12.36.1 Applied Biomics Company Information
- 12.36.2 Applied Biomics Business Overview
- 12.36.3 Applied Biomics Revenue in Proteomics Research Services Business (2021-2026)
- 12.36.4 Applied Biomics Proteomics Research Services Product Portfolio
- 12.36.5 Applied Biomics Recent Developments
- 12.37 Westlake Omics
- 12.37.1 Westlake Omics Company Information
- 12.37.2 Westlake Omics Business Overview
- 12.37.3 Westlake Omics Revenue in Proteomics Research Services Business (2021-2026)
- 12.37.4 Westlake Omics Proteomics Research Services Product Portfolio
- 12.37.5 Westlake Omics Recent Developments
- 12.38 Sapient Bioanalytics
- 12.38.1 Sapient Bioanalytics Company Information
- 12.38.2 Sapient Bioanalytics Business Overview
- 12.38.3 Sapient Bioanalytics Revenue in Proteomics Research Services Business (2021-2026)
- 12.38.4 Sapient Bioanalytics Proteomics Research Services Product Portfolio
- 12.38.5 Sapient Bioanalytics Recent Developments
- 12.39 RxCelerate
- 12.39.1 RxCelerate Company Information
- 12.39.2 RxCelerate Business Overview
- 12.39.3 RxCelerate Revenue in Proteomics Research Services Business (2021-2026)
- 12.39.4 RxCelerate Proteomics Research Services Product Portfolio
- 12.39.5 RxCelerate Recent Developments
- 12.40 Vizgen
- 12.40.1 Vizgen Company Information
- 12.40.2 Vizgen Business Overview
- 12.40.3 Vizgen Revenue in Proteomics Research Services Business (2021-2026)
- 12.40.4 Vizgen Proteomics Research Services Product Portfolio
- 12.40.5 Vizgen Recent Developments
- 12.41 Allumiqs
- 12.41.1 Allumiqs Company Information
- 12.41.2 Allumiqs Business Overview
- 12.41.3 Allumiqs Revenue in Proteomics Research Services Business (2021-2026)
- 12.41.4 Allumiqs Proteomics Research Services Product Portfolio
- 12.41.5 Allumiqs Recent Developments
- 12.42 VProteomics
- 12.42.1 VProteomics Company Information
- 12.42.2 VProteomics Business Overview
- 12.42.3 VProteomics Revenue in Proteomics Research Services Business (2021-2026)
- 12.42.4 VProteomics Proteomics Research Services Product Portfolio
- 12.42.5 VProteomics Recent Developments
- 12.43 Precision Biomarker Laboratories (PBL)
- 12.43.1 Precision Biomarker Laboratories (PBL) Company Information
- 12.43.2 Precision Biomarker Laboratories (PBL) Business Overview
- 12.43.3 Precision Biomarker Laboratories (PBL) Revenue in Proteomics Research Services Business (2021-2026)
- 12.43.4 Precision Biomarker Laboratories (PBL) Proteomics Research Services Product Portfolio
- 12.43.5 Precision Biomarker Laboratories (PBL) Recent Developments
- 12.44 Proteome Sciences
- 12.44.1 Proteome Sciences Company Information
- 12.44.2 Proteome Sciences Business Overview
- 12.44.3 Proteome Sciences Revenue in Proteomics Research Services Business (2021-2026)
- 12.44.4 Proteome Sciences Proteomics Research Services Product Portfolio
- 12.44.5 Proteome Sciences Recent Developments
- 12.45 Proteomics International
- 12.45.1 Proteomics International Company Information
- 12.45.2 Proteomics International Business Overview
- 12.45.3 Proteomics International Revenue in Proteomics Research Services Business (2021-2026)
- 12.45.4 Proteomics International Proteomics Research Services Product Portfolio
- 12.45.5 Proteomics International Recent Developments
- 12.46 TATAA Biocenter
- 12.46.1 TATAA Biocenter Company Information
- 12.46.2 TATAA Biocenter Business Overview
- 12.46.3 TATAA Biocenter Revenue in Proteomics Research Services Business (2021-2026)
- 12.46.4 TATAA Biocenter Proteomics Research Services Product Portfolio
- 12.46.5 TATAA Biocenter Recent Developments
- 12.47 Cosmos Wisdom
- 12.47.1 Cosmos Wisdom Company Information
- 12.47.2 Cosmos Wisdom Business Overview
- 12.47.3 Cosmos Wisdom Revenue in Proteomics Research Services Business (2021-2026)
- 12.47.4 Cosmos Wisdom Proteomics Research Services Product Portfolio
- 12.47.5 Cosmos Wisdom Recent Developments
- 12.48 Olink (Thermo Fisher Scientific)
- 12.48.1 Olink (Thermo Fisher Scientific) Company Information
- 12.48.2 Olink (Thermo Fisher Scientific) Business Overview
- 12.48.3 Olink (Thermo Fisher Scientific) Revenue in Proteomics Research Services Business (2021-2026)
- 12.48.4 Olink (Thermo Fisher Scientific) Proteomics Research Services Product Portfolio
- 12.48.5 Olink (Thermo Fisher Scientific) Recent Developments
- 12.49 SomaLogic (Illumina)
- 12.49.1 SomaLogic (Illumina) Company Information
- 12.49.2 SomaLogic (Illumina) Business Overview
- 12.49.3 SomaLogic (Illumina) Revenue in Proteomics Research Services Business (2021-2026)
- 12.49.4 SomaLogic (Illumina) Proteomics Research Services Product Portfolio
- 12.49.5 SomaLogic (Illumina) Recent Developments
- 12.50 CellCarta
- 12.50.1 CellCarta Company Information
- 12.50.2 CellCarta Business Overview
- 12.50.3 CellCarta Revenue in Proteomics Research Services Business (2021-2026)
- 12.50.4 CellCarta Proteomics Research Services Product Portfolio
- 12.50.5 CellCarta Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst